These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2683030)

  • 1. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Rainsford KD
    Scand J Gastroenterol Suppl; 1989; 163():9-16. PubMed ID: 2683030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
    Fromm D
    Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of gastrointestinal damage by NSAIDS.
    Rainsford KD
    Agents Actions Suppl; 1993; 44():59-64. PubMed ID: 8372736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of gastric and duodenal damage and protection.
    Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural damage and changes in eicosanoid metabolites in the gastric mucosa of rats and pigs induced by anti-inflammatory drugs of varying ulcerogenicity.
    Rainsford KD
    Int J Tissue React; 1986; 8(1):1-14. PubMed ID: 3949439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake.
    Rainsford KD; Fox SA; Osborne DJ
    Scand J Gastroenterol Suppl; 1984; 101():55-68. PubMed ID: 6443622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.
    Petruzzelli M; Vacca M; Moschetta A; Cinzia Sasso R; Palasciano G; van Erpecum KJ; Portincasa P
    Clin Biochem; 2007 May; 40(8):503-10. PubMed ID: 17321514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?
    Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():9-39. PubMed ID: 7697906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP
    Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal toxicity. Role of prostaglandins and leukotrienes.
    Peskar BM; Kleine A; Pyras F; Müller MK
    Med Toxicol; 1986; 1 Suppl 1():39-43. PubMed ID: 3547000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biochemical protective mechanisms against non-steroidal anti-inflammatory drug induced G-I mucosal damage.
    Rainsford KD
    Acta Physiol Hung; 1989; 73(2-3):261-78. PubMed ID: 2512767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
    Wallace JL; Vong L
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric mucosal damage by nonsteroidal anti-inflammatory drugs.
    Bennett A
    Int J Tissue React; 1989; 11(2):53-7. PubMed ID: 2693388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some new aspects of gastric mucosal protection and damage.
    Bennett A
    Acta Physiol Hung; 1989; 73(2-3):179-83. PubMed ID: 2688358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment.
    Rainsford KD
    J Pharm Pharmacol; 1987 Aug; 39(8):669-72. PubMed ID: 2888866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.